Disclaimer
is Guideline attempts to define principles of practice that should produce high-quality patient
care. It is applicable to specialists, primary care practitioners, and providers at all levels. is
Guideline should not be considered exclusive of other methods of care reasonably directed at
obtaining the same results. e ultimate judgment concerning the propriety of any course of
conduct must be made by the clinician aer consideration of each individual patient situation.
Neither IGC, the medical associations, nor the authors endorse any product or service associated
with the distribution of this clinical reference tool.
Abbreviations
ACE, angiotensin-converting enzyme; ADA, American Diabetes Association; ARB,
angiotensin-receptor blocker; BP, blood pressure; CAD, coronary artery disease; DCCT,
Diabetes Control and Complications Trial; GFR, glomerular filtration rate; HbA1c,
hemoglobin A1c (glycohemoglobin); IADPSG, International Association of Diabetes and
Pregnancy Study Groups; IOM, Institute of Medicine; MNT, medical nutrition therapy;
NCGP, National Glycohemoglobin Standardization Program; NPH, neutral protamine
Hagedorn; OGTT, oral glucose tolerance test; SC, subcutaneous; ES, Endocrine Society;
TSH, thyroid stimulating hormone
Source
Blumer I, Hadar E, Hadden DR, Jovanovič L, Mestman JH, Murad MH, Yogev Y.
Diabetes and pregnancy: an Endocrine Society clinical practice guideline. J Clin
Endocrinol Metab. 2013;98(11):4227-4249.
106 Commerce Street, Suite 105
Lake Mary, FL 32746
TEL: 407.878.7606 • FAX: 407.878.7611
For additional copies: info@GuidelineCentral.com
Copyright © 2014 All rights reserved
ESDIPRE14023
Grading System
Strength of
Recommendation
1 = strong 2 = less strong U = Ungraded
Quality of
Evidence
⊕⊕⊕⊕
= high
⊕⊕⊕
= moderate
⊕⊕
= low
⊕
= very low
